Sonolisib
| Supplier | MedChemExpress |
|---|---|
| Product # | HY-N6775-5 mg |
| CAS # | 502632-66-8 |
| Pricing | 5 mg, USD $420.0 |
| Synonyms | PX-866 |
| MWt | 525.59 |
| Formula | C₂₉H₃₅NO₈ |
| Biological Activity | Sonolisib (PX-866), an improved Wortmannin analogue, is an oral, irreversible, and pan-isoform inhibitor of PI3K (IC50=0.1 nM (p110α), 1.0 nM (p120γ), 2.9 nM (p110δ)). Antitumor activity[1][2]. |
| Purity | ≥99.0% |